Michael Gelband’s Atreca, Inc. Class A Common Stock BCEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-466,828
Closed -$457K 2259
2023
Q2
$457K Sell
466,828
-43,058
-8% -$44.3K ﹤0.01% 1390
2023
Q1
$581K Buy
509,886
+398,116
+356% +$578K ﹤0.01% 1298
2022
Q4
$89K Buy
+111,770
New +$142K ﹤0.01% 1525
2022
Q1
Sell
-17,167
Closed -$52K 2785
2021
Q4
$52K Sell
17,167
-4,274
-20% -$20K ﹤0.01% 2029
2021
Q3
$134K Sell
21,441
-4,336
-17% -$28.9K ﹤0.01% 1863
2021
Q2
$220K Buy
+25,777
New +$264K ﹤0.01% 1923

Other funds holding BCEL

Michael Gelband's BCEL Position: Q3 2023 in Review

Michael Gelband sold out of Atreca, Inc. Class A Common Stock (BCEL) in Q3 2023, closing a stake of 466,828 shares — an estimated $457K sold.

Michael Gelband first reported a position in BCEL in Q2 2021 and held it in 6 quarters. The position peaked at $581K in Q1 2023. 45 funds tracked by Wall St. Rank hold BCEL as of Q3 2023.

  • Michael Gelband reported no remaining Atreca, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
  • Michael Gelband sold 466,828 Atreca, Inc. Class A Common Stock shares in Q3 2023, an estimated $457K.
  • Michael Gelband first reported a position in Atreca, Inc. Class A Common Stock in Q2 2021 and held it in 6 quarters.
  • Michael Gelband's Atreca, Inc. Class A Common Stock position peaked at $581K in Q1 2023.
  • 45 funds tracked by Wall St. Rank held Atreca, Inc. Class A Common Stock as of Q3 2023.

Based on ExodusPoint Capital Management's 13F filing for Q3 2023, filed 13 Nov 2023.